Graticule Asia Macro Advisors LLC Guardant Health, Inc. Transaction History

Graticule Asia Macro Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $1.58 Million - $2.11 Million	-16,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $8.05 Million - $12.2 Million	-73,380 Reduced 82.1%	16,000 $1.99 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $11.4 Million - $16 Million	89,380 New	89,380 $13.6 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.